Trial NCT00070122

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02556
Secondary IDs: CDR0000330000 S0303 U10CA032102

Last trial update was posted on 2013-01-25

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Capecitabine Fluorouracil Immunoglobulins Leucovorin Levoleucovorin Oxaliplatin

MeSH Conditions

Adenocarcinoma Colonic Neoplasms Rectal Neoplasms Recurrence

Other Conditions

Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID